Indeed, RAIAs induces a faster rise in plasma concentration, a higher peak concentration and a shorter subcutaneous residence time, which results in reduced PP glucose excursions and a lower risk of late hypoglycemia compared to regular human insulin [69,70]. This evidence concerns the gene INS and Hypoglycemia.